The first probiotic with a European health claim is now a fact, according to Dutch probiotic researcher and manufacturer Winclove Probiotics. Winclove’s upgraded Propionibacterium freudenreichii W200 contains adequate amounts of vitamin B12 to make an EFSA approved health claim.
Marco van Es, Director Business Development at Winclove: “Stringent probiotic regulations drive the market to innovation. We have succeeded in optimizing the fermentation process of Propionibacterium freudenreichii W200 in such a way that it now produces substantial amounts of vitamin B12. It is the first probiotic in Europe that allows EFSA approved health claims. W200 opens up new opportunities for dietary supplement marketers to promote the health benefits of probiotics to health care professionals and consumers”.
With the upgraded Propionibacterium freudenreichii W200 the following 8 EFSA health claims can be made:
According to the WHO probiotics are defined as “live micro-organisms which, when administered in adequate amounts, confer a health beneﬁt on the host”. Although this definition is widely adopted, European national regulatory authorities forbid the use of the word “probiotic” since it embeds a non-validated health claim. So far, EFSA has rejected all submitted health claims for probiotics. The upgraded Propionibacterium freudenreichii W200 would be the first strain with an approved health claim, implying the first probiotic that can truly be called a probiotic.
Vitamin B12, a water-soluble vitamin also called cobalamin, is involved in the metabolism of every cell of the human body and is only produced through a bacterial fermentation-synthesis. Propionibacteria are already known for producing vitamin B12, however in small amounts.
Winclove has over 25 years of experience in researching, developing and manufacturing evidence-based probiotics. The company offers an extensive portfolio ranging from probiotics for traditional gastrointestinal disorders to innovative mental health solutions. Through close collaboration with customers, thought leaders and research institutes worldwide, Winclove combines knowledge and experience with a passion for innovation to deliver unmatched probiotics to the market. The company is committed to transforming lives of patients with probiotics developed through innovative microbiome science.
For more information about Winclove, please visit www.wincloveprobiotics.com